Johns Hopkins Center for Clinical Global Health Education

What Johns Hopkins Center for Clinical Global Health Education does

The Johns Hopkins Center for Clinical Global Health Education (CCGHE) is a research and education center within Johns Hopkins School of Medicine, founded in 1990 and headquartered in Baltimore, Maryland. It conducts multi-country clinical research and training programs focused on infectious diseases — primarily HIV/AIDS, tuberculosis, and COVID-19 — in resource-limited settings across more than 10 countries in South Asia, sub-Saharan Africa, Southeast Asia, and Latin America. The center's technology portfolio includes the emocha mobile health platform (invented in 2007 and licensed to emocha Mobile Health Inc. in 2013), HIV-ASSIST clinical decision support software for antiretroviral therapy selection, the miLAB lab-on-a-chip diagnostic co-developed with imec and miDIAGNOSTICS, and the SCARP COVID-19 severity prediction model published in Annals of Internal Medicine.

CCGHE operates as a grant-funded academic entity rather than a commercial enterprise. Its revenue derives from NIH, CDC, PEPFAR, and Fogarty International Center research and training grants, supplemented by indirect royalty streams from the emocha licensing arrangement that flow through Johns Hopkins University. Its customer base consists of federal funders, in-country academic and clinical partners (notably BJGMC in Pune, RHSP in Uganda, MESAU consortium, and NIRT in Chennai), and global health research networks including ACTG, IMPAACT, and RePORT International. The center does not sell commercial products, has no disclosed pricing model, and operates with a small core staff of 11–50 personnel supplemented by global research collaborators and trainees.

Name

Johns Hopkins Center for Clinical Global Health Education

Legal name

Center for Clinical Global Health Education

Website

https://main.ccghe.net

Company type

Private

Founded year

1990

Operating status

Operating

Headcount range

11–50 employees

Short description

CCGHE is a Johns Hopkins School of Medicine research center conducting multi-country clinical research and training on HIV, tuberculosis, and COVID-19 in resource-limited settings, funded primarily by NIH, CDC, and PEPFAR grants.

Ownership category

akta.pro rank

Product category

Global Health Research and Education

NAICS

Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171), Educational Support Services (611710)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Educational Services (8200)

akta.pro primary industry

Global Health Research, Clinical Trials & Product Development Partnerships (PDPs) (HLAJAOAM)

akta.pro secondary industry

Clinical Research Support (CRC/CTA) (EDAOAJAO)

Keywords

• Global health research
• Infectious disease training
• MHealth platforms
• Clinical trial networks
• Point-of-care diagnostics

Headquarters

HQ city

Baltimore

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Grant Funding and Research Contracts: As an academic research center within Johns Hopkins School of Medicine, CCGHE operates primarily through NIH, CDC, PEPFAR, and foundation grant funding for clinical research, education programs, and technology development.
2. Technology Licensing: Johns Hopkins University licensed the emocha platform to emocha Mobile Health, Inc. in 2013. CCGHE staff (Dr. Bollinger, Dr. Chang, Ms. McKenzie-White, Dr. Page, Dr. Shah) are inventors and have royalty interests in emocha. This represents a licensing revenue stream to Johns Hopkins University.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

CCGHE is an academic research and education center within Johns Hopkins School of Medicine that conducts clinical trials, scholar training programs, and technology development focused on infectious diseases (HIV, TB, COVID-19) in resource-limited settings across more than 10 countries. It develops proprietary mHealth platforms (emocha), clinical decision support tools (HIV-ASSIST), point-of-care diagnostics (miLAB), and risk prediction calculators (SCARP), and delivers open-access grand rounds, case conferences, and field research training.

Product overview

The Johns Hopkins Center for Clinical Global Health Education operates as a research and education organization rather than a traditional product company. Its technology portfolio consists of health technology innovations developed by its faculty, including the emocha® Mobile Health Platform for medication adherence and telemedicine, HIV-ASSIST for clinical decision support in HIV treatment, miLAB (lab on a chip) for point-of-care diagnostics, and SCARP for COVID-19 risk prediction. These tools are primarily used within research collaborations and have varying levels of commercialization, with emocha® having been licensed to a separate company (emocha Mobile Health, Inc.) in 2013.

Differentiator

Problem solved

Functional benefit

Products and services

• emocha® Mobile Health Platform A mobile health platform enabling secure sharing of health data, multimedia communication, and education between providers and patients in remote, low-connectivity settings. Supports telemedicine visits and adherence to best-practice algorithms. Used for HIV linkage-to-care, TB, oral cancer screening, and other global health use cases.
• HIV-ASSIST An online clinical decision support resource for HIV care providers that ranks preferred antiretroviral therapy regimens based on patient attributes including drug resistance, comorbidities, comedications, viral load, CD4, tropism, and HLA status, according to likelihood of viral suppression and tolerability.
• miLAB Clinical Lab on a Chip A portable, temperature-control-free diagnostic platform requiring only a few drops of blood to process cell, protein, nucleic acid, and small molecule samples and deliver results within minutes without a laboratory. Designed for point-of-need testing in remote areas.
• SCARP (Severe COVID-19 Adaptive Risk Predictor) A real-time calculator that predicts severe disease or death among hospitalized COVID-19 patients based on electronic health record data. Published in Annals of Internal Medicine.
• CCGHE Scholar Training Programs Fogarty International Center-funded training programs offering field study opportunities in India, research electives at JHU, and formal mentoring for graduate students, medical residents, and junior researchers in infectious diseases and global health.
• COVID-19 Grand Rounds An open-access educational series offering clinical cases, in-depth literature reviews, and infectious disease expertise from Johns Hopkins School of Medicine relevant to the care of SARS-CoV-2 patients.
• TB Case Conferences and Clinical Case Discussions Open-access live TB case conferences and clinical case discussion video conferences broadcast globally with archived webcasts available through the CCGHE website.

Quantifiable outcome

• Combination HIV prevention reduced new HIV infections by 42% in Uganda
• +3 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Ten partnerships are on record, tiered core and minor.

• Medical Education Services to All Ugandans (MESAU)coreStrategic or Co-development PartnerMESAU is a consortium of five Ugandan medical schools. CCGHE partnered with MESAU to provide support across five strategic areas: monitoring and evaluation, research capacity building, IRB strengthening, curriculum development, and IT/distance learning.
• emocha Mobile Health, Inc.coreOEM/ Whitelabel/ Licensing PartnerJohns Hopkins University licensed the emocha platform to emocha Mobile Health, Inc. in 2013. CCGHE inventors (Dr. Bollinger, Dr. Chang, Ms. McKenzie-White, Dr. Page, Dr. Shah) have royalty interests and Dr. Bollinger serves on the emocha Board of Directors. emocha has become a leader in medication adherence support for TB, asthma, HIV, HCV, organ transplant, and diabetes.
• imec and miDIAGNOSTICScoreTechnology or IntegrationInternational public-private collaboration with Belgium silicon chip engineering company imec and miDIAGNOSTICS to develop the miLAB clinical lab on a chip. The technology has potential to radically transform healthcare with point-of-care diagnostics.
• Byramjee Jeejeebhoy Government Medical College (BJGMC) Clinical Research SitecoreStrategic or Co-development PartnerBJGMC in Pune, India is the largest HIV clinic in India with over 26,000 adult and pediatric patients registered since 2005. CCGHE leads several Indo-JHU research collaborations at this site including C-TRIUMPH, ACTG, and IMPAACT clinical trials.
• Rakai Health Sciences Program (RHSP), UgandacoreStrategic or Co-development PartnerMulti-year research partnership for HIV prevention, treatment, and epidemiology studies in Rakai, Uganda. CCGHE researchers (Dr. Larry Chang and others) have conducted extensive research on combination HIV prevention, community health worker interventions (mLAKE study), and HIV incidence in fishing communities with HIV prevalence of approximately 38%.
• AIDS Clinical Trials Group (ACTG)coreStrategic or Co-development PartnerCCGHE faculty are active clinical investigators in multi-country trials conducted by ACTG, with protocol chair roles for high-impact studies resulting in publications in NEJM and The Lancet. Dr. Amita Gupta serves as Protocol Vice-Chair of key ACTG protocols.
• International Maternal Pediatric Adolescent AIDS Trials Network (IMPAACT)coreStrategic or Co-development PartnerCCGHE investigators participate in IMPAACT network trials, particularly focused on TB and HIV in pregnancy, with Dr. Amita Gupta serving as Scientific Committee Vice-Chair for IMPAACT TB and leading studies on pharmacokinetics of antiretroviral and anti-TB drugs during pregnancy.
• RePORT India ConsortiumcoreStrategic or Co-development PartnerDr. Amita Gupta serves as US Chair of RePORT India TB Research Consortium, part of RePORT International, a multilateral global consortia for TB research. Funded by NIH and India's Department of Biotechnology. Collaborative TB research consortium part of RePORT International.
• Makerere University College of Health Sciences, UgandaminorStrategic or Co-development PartnerPart of MESAU consortium. Makerere University collaborated with JHU through the COBERS (Community-Based Education, Research and Service) program to strengthen health professional interdisciplinary education and research training.
• National Institute for Research in Tuberculosis (NIRT), IndiacoreStrategic or Co-development PartnerNIRT in Chennai, India is a key partner for TB research including C-TRIUMPH cohort studies, biomarker research, and pediatric TB studies in collaboration with CCGHE and BJGMC.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• London School of Hygiene & Tropical Medicine: Leading global health institution with deep HIV/TB clinical trial portfolios, LMIC research sites, and scholar training programs. Highly comparable as a multi-country infectious disease research and education organization.
• Harvard Global Health Institute: Harvard's cross-school global health hub that conducts multi-country infectious disease research, trains scholars, and partners with LMIC institutions. Comparable as a peer university-based global health research and education center with overlapping funder base and disease focus.

Direct peers

• Brigham and Women's Hospital Division of Global Health Equity: Harvard-affiliated hospital-based global health research group with HIV/TB clinical trials in LMICs and partner institution training. Directly comparable as a peer academic medical center global health unit.
• UC San Diego Center for Global Health: U.S. academic medical center global health hub conducting HIV/TB clinical trials and training scholars internationally. Comparable structure, scope, and university-hospital affiliation.
• Emory Global Health Institute: Emory's interdisciplinary global health hub with significant HIV/TB research, CDC proximity advantages, and LMIC partnerships. Comparable peer in infectious-disease-focused academic global health.
• University of Washington Department of Global Health: Major U.S. academic global health department with extensive HIV/TB/maternal health research in LMICs, mHealth technology development, and large NIH-funded trial portfolios. Closely parallels CCGHE in research scope and funding model.
• Medic (formerly Medic Mobile): Nonprofit building open-source mHealth platforms deployed with community health workers in LMICs. Comparable as a digital health platform for frontline health workers in resource-limited settings, directly overlapping emocha's deployment model.
• Duke Global Health Institute: University-based global health research and education center with multi-country infectious disease trials and training programs. Comparable in scale, academic affiliation, and NIH-funded research model.

Others

• NIH Fogarty International Center: The primary U.S. funder of CCGHE's training programs for nearly three decades; comparable as a research training and capacity-building organization, though operating as a federal agency rather than a university center.

Regional players

• WHO Special Programme for Research and Training in Tropical Diseases (TDR): Multilateral funder and research convener for tropical diseases in LMICs, co-sponsored by UNICEF, UNDP, World Bank, and WHO. Comparable in scope of infectious disease research coordination and scholar training, though operating globally rather than from a single country.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/HopkinsCCGHE
• Facebookfacebook.com/CCGHE
• LinkedInlinkedin.com/company/johns-hopkins-center-for-clinical-global-health-education

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Johns Hopkins Center for Clinical Global Health Education